Remix Therapeutics
Remix Therapeutics is a startup headquartered in Watertown, United States, founded in 2019. It has raised at least $13.7m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Remix Therapeutics has raised at least $13.7m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Remix Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Watertown
- Abata Therapeutics
- Affini-T Therapeutics
- Averna Therapeutics
- Corner Therapeutics
- Elastro
- EnPlusOne Biosciences
- Entact Bio
- Multitude Insights
- PathCision Medicine
- Treeline Biosciences
- Tutor Intelligence
Related
Questions and answers
What does Remix Therapeutics do?
Remix Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Remix Therapeutics raised?
At least $13.7m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Remix Therapeutics based?
Remix Therapeutics is headquartered in Watertown, United States.
When was Remix Therapeutics founded?
Remix Therapeutics was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.